Tissue engineering of bone: Cell based strategies

Clinical Orthopaedics and Related Research

Volumn 367, Issue SUPPL., 1999, Pages

  Bruder, Scott P ^a,b,c   Fox, Barbara S ^b  

^a Anika Therapeutics   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Anika Therapeutics Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOENGINEERING; BONE REGENERATION; BONE REMODELING; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; HUMAN; OSSIFICATION; PRIORITY JOURNAL;

EID: 0032758946     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199910001-00008     Document Type: Conference Paper

References (64)

1. Beresford JN: Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 240:270-280, 1989.
2. Breitbart AS, Grande DA, Kessler R, et al: Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast Reconstr Surg 101: 567-574, 1998.
3. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE: Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 21:225-235, 1997.
4. Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294, 1997.
5. Bruder SP, Jaiswal N, Ricalton NS, et al: Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop 355 (Suppl):S247-S256, 1998.
6. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S: The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg 80A:985-996, 1998.
7. Bruder SP, Kurth AA, Shea M, et al: Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16: 155-162, 1998.
8. Bruder SP, Ricalton NS, Boynton R, et al: Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 13: 655-663, 1998.
9. Bucholz RW, Carlton A, Holmes RE: Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 18:323-334, 1987.
10. Connolly JF, Guse R, Lippiello L, Dehne R: Development of an osteogenic bone-marrow preparation. J Bone Joint Surg 71A:684-691, 1989.
11. Connolly JF, Guse R, Tiedeman J, Dehne R: Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop 266:259-270, 1991.
12. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC: Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301:302-312, 1994.
13. Cook SD, Wolfe MW, Salkeld SL, Rueger DC: Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg 77A:734-750, 1995.
14. Cummine J, Armstrong L, Nade S: Osteogenesis after bone and bone marrow transplantation. Acta Orthop Scand 54:235-241, 1983.
15. Dennis JE, Haynesworth SE, Young RG, Caplan AI: Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: Effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1:23-32, 1992.
16. Egrise D, Martin D, Vienne A, Neve P, Schouten A: The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone 13: 355-361, 1992.
17. Einhorn TA, Lane JM, Burstein AH, Kopman CR, Vigorita VJ: The healing of segmental bone defects induced by demineralized bone matrix. J Bone Joint Surg 66A:274-279, 1984.
18. Feighan JE, Davy D, Prewett A, Stevenson S: Induction of bone by a demineralized bone matrix gel: A study in a rat femoral detect model. J Orthop Res 13:881-891, 1995.
19. Friedenstein AJ: Precursor cells of mechanocytes. Int Rev Cytol 47:327-355, 1976.
20. Gerhart TN, Kirker-Head CA, Kriz MJ, et al: Healing segmental femoral defects in sheep using recombinant human bone morphosenetic protein. Clin Orthop 293:317-326, 1993.
21. Grundel RE, Chapman MW, Yee T, Moore DC: Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop 266: 244-258, 1991.
22. Haynesworth SE, Baber MA, Caplan AI: Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69-80, 1992.
23. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI: Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88, 1992.
24. Heckman JD, Boyan BD, AufdemorteTB, Abbot JT: The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg 73A:750-764, 1991.
25. Hollinger JO, Brekke J, Gruskin E, Lee D: Role of bone substitutes. Clin Orthop 324:55-65, 1996.
26. Holmes RE, Bucholz RW, Mooney V: Porous hydroxyapatite as a bone graft substitute in diaphyseal defects: A histometric study. J Orthop Res 5:114-121, 1987.
27. Hunt TR, Schwappach JR, Anderson HC: Healing of a segmental defect in the rat femur with use of an extract from a cultured human osteosarcoma cell-line (Saos-2). A preliminary report. J Bone Joint Surg 78A:41-48, 1996.
28. Inoue K, Ohgushi H, Yoshikawa T, et al: The effect of aging on bone formation in porous hydroxyapatite: Biochemical and histological analysis. J Bone Miner Res 12:989-994, 1997.
29. Ishaug SL, Crane GM, Miller MJ, et al: Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36:17-28, 1997.
30. Ishaug-Riley SL, Crane GM, Gurlek A, et al: Ectopic bone formation by marrow stromal osteoblast transplantation using poly (DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res 36:1-8, 1997.
31. Jackson IT, Scheker LR, Vandervord JG, et al: Bone marrow grafting in the secondary closure of alveolar-palatal defects in children. Br J Plast Surg 34: 422-425, 1981.
32. Johnson KD, Frierson KE, Keller TS, et al: Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis. J Orthop Res 14:351-369, 1996.
33. Kadiyala S, Jaiswal N, Bruder SP: Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Eng 3:173-185, 1997.
34. Kadiyala S, Young RG, Thiede MA, Bruder SP: Culture-expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6:125-134, 1997.
35. Kahn A, Gibbons R, Perkins S, Gazit D: Age-related bone loss: A hypothesis and initial assessment in mice. Clin Orthop 313:69-75, 1995.
36. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI: Development of a serum screen for mesenchymal progenitor cells from bone marrow. In Vitro Cell Dev Biol 32:602-611, 1996.
37. Liang CT, Barnes J, Seedor JG, et al: Impaired bone activity in aged rats: Alterations at the cellular and molecular levels. Bone 13:435-141, 1992.
38. Lieberman JR, Le LQ, Wu L, et al: Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16:330-339, 1998.
39. Lieberman JR, Stevenson S, Wu L, et al: Adenoviral gene transfer of recombinant BMP-2 into human and rodent bone marrow cell induces bone formation in vivo. Trans Orthop Res Soc 43: 427, 1997.
40. Maniatopoulos C, Sodek J, Melcher AH: Bone formation in vitro by stromal cells obtained from marrow of young adult rats. Cell Tissue Res 254: 317-330, 1988.
41. Mayer M, Hollinger J, Ron E, Wozney J: Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast Reconstr Surg 98:247-259, 1996.
42. Moore DC, Chapman MW, Manske D: The evaluation of a biphasic calcium phosphate ceramic for use in grafting long-bone diaphyseal defects. J Orthop Res 5:356-365, 1987.
43. Nakahara H, Bruder SP, Goldberg VM, Caplan AI: In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop 259:223-232, 1990.
44. Ohgushi H, Goldberg VM, Caplan A: Repair of bone defects with marrow cells and porous ceramics. Acta Orthop Scand 60:334-339, 1989.
45. Ohgushi H, Goldberg VM, Caplan AI: Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 7:568-578, 1989.
46. Okumura M, Ohgushi H, Dohi Y, et al: Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 37:122-129, 1997.
47. Owen M: Lineage of Osteogenic Cells and Their Relationship to the Stromal System. In Peck WJ (ed). Bone and Mineral. Ed 3. Amsterdam, Elsevier 1-25, 1985.
48. Paley D, Young MC, Wiley AM, Fornasier VL, Jackson RW: Percutaneous bone marrow grafting of fractures and bony defects: An experimental study in rabbits. Clin Orthop 208:300-312, 1986.
49. Pereira RF, Halford KW, O'Hara MD, et al: Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92:4857-4861, 1995.
50. Pittenger MF, Mackay AM, Beck SC, et al: Multi-lineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999.
51. Quarto R, Thomas D, Liang T: Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 56:123-129, 1995.
52. Salama R, Weissman SL: The clinical use of combined xenografts of bone and autologous red marrow. J Bone Joint Surg 60B:111-121, 1978.
53. Schmitz JP, Hollinger JO: The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 205:299-308, 1986.
54. Stevenson S, Cunningham N, Toth J, Davy D, Reddi AH: The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. J Bone Joint Surg 76A: 1676-1687, 1994.
55. Tabuchi C, Simmon DJ, Fausto A, et al: Bone deficit in ovariectomized rats. J Clin Invest 78:637-642, 1986.
56. Tomin E, Lane JM, Nakamichi K, et al: Performance of molded vascularized bone grafts induced by BMP-2 and marrow in a rat segmental defect model. Trans Orthop Res Soc 24:621, 1999.
57. Tsuji T, Hughes FJ, McCulloch CA, Melcher AH: Effect of donor age on osteogenic cells of rat bone marrow in vitro. Mech Ageing Dev 51:121-132, 1990.
58. Vacanti CA, Kim W, Upton J, Mooney D, Vacanti JP: The efficacy of periosteal cells compared to chondrocytes in the tissue engineered repair of bone defects. Tissue Eng 1:301-308, 1995.
59. Vacanti CA, Mikos AG: Letter from the editors. Tissue Eng 1:1-2, 1995.
60. Wakitani S, Goto T, Pineda SJ, et al: Mesenchymal cell-based repair of large full-thickness defects of articular cartilage. J Bone Joint Surg 76A:579-592, 1994.
61. Werntz JR, Lane JM, Burstein AH, et al: Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. J Orthop Res 14:85-93, 1996.
62. Wolff D, Goldberg VM, Stevenson S: Histomorphometric analysis of the repair of a segmental diaphyseal defect with ceramic and titanium fibermetal implants: Effects of bone marrow. J Orthop Res 12:439-446, 1994.
63. Yasko AW, Lane JM, Fellinger EJ, et al: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg 74A:659-670, 1992.
64. Yoshikawa T, Ohgushi H, Tamai S: Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res 32:481-492, 1996.